Mereo BioPharma (MREO) Shareholder's Equity (2017 - 2026)

Mereo BioPharma (MREO) Shareholder's Equity (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 7.14 Bn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 795.79 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 595,226.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 1.00 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 14.38 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 19.36 Bn
9 Abivax 91.96 Bn 91.96 Bn - 502.95 Mn
10 Mereo BioPharma 252.49 Mn 252.49 Mn - 34.05 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 34.05 Mn
Dec 31, 2025 40.92 Mn
Sep 30, 2025 46.60 Mn
Jun 30, 2025 54.18 Mn
Mar 31, 2025 60.08 Mn
Dec 31, 2024 60.97 Mn
Sep 30, 2024 -72.54 Mn
Jun 30, 2024 78.65 Mn
Mar 31, 2024 42.84 Mn
Dec 31, 2023 50.54 Mn
Sep 30, 2023 54.71 Mn
Jun 30, 2023 49.67 Mn
Mar 31, 2023 44.40 Mn
Dec 31, 2022 51.40 Mn
Dec 31, 2018 42.17 Mn
Dec 31, 2017 82.96 Mn